228 related articles for article (PubMed ID: 17583177)
1. Trandolapril/verapamil combination in hypertensive diabetic patients.
García Donaire JA; Ruilope LM
Vasc Health Risk Manag; 2007; 3(1):77-82. PubMed ID: 17583177
[TBL] [Abstract][Full Text] [Related]
2. Preclinical considerations and results with the combination of verapamil and trandolapril: blood pressure reduction and beyond.
Kirchengast M
J Hypertens Suppl; 1997 Mar; 15(2):S27-33. PubMed ID: 9218195
[TBL] [Abstract][Full Text] [Related]
3. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.
Pepine CJ; Handberg EM; Cooper-DeHoff RM; Marks RG; Kowey P; Messerli FH; Mancia G; Cangiano JL; Garcia-Barreto D; Keltai M; Erdine S; Bristol HA; Kolb HR; Bakris GL; Cohen JD; Parmley WW;
JAMA; 2003 Dec; 290(21):2805-16. PubMed ID: 14657064
[TBL] [Abstract][Full Text] [Related]
4. Impact of blood pressure control and angiotensin-converting enzyme inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: a post hoc analysis of the BENEDICT trial.
Ruggenenti P; Perna A; Ganeva M; Ene-Iordache B; Remuzzi G;
J Am Soc Nephrol; 2006 Dec; 17(12):3472-81. PubMed ID: 17082240
[TBL] [Abstract][Full Text] [Related]
5. Preventing microalbuminuria in type 2 diabetes.
Ruggenenti P; Fassi A; Ilieva AP; Bruno S; Iliev IP; Brusegan V; Rubis N; Gherardi G; Arnoldi F; Ganeva M; Ene-Iordache B; Gaspari F; Perna A; Bossi A; Trevisan R; Dodesini AR; Remuzzi G;
N Engl J Med; 2004 Nov; 351(19):1941-51. PubMed ID: 15516697
[TBL] [Abstract][Full Text] [Related]
6. Fixed combination trandolapril/verapamil sustained-release: a review of its use in essential hypertension.
Muijsers RB; Curran MP; Perry CM
Drugs; 2002; 62(17):2539-67. PubMed ID: 12421112
[TBL] [Abstract][Full Text] [Related]
7. Predictors of adverse outcome among patients with hypertension and coronary artery disease.
Pepine CJ; Kowey PR; Kupfer S; Kolloch RE; Benetos A; Mancia G; Coca A; Cooper-DeHoff RM; Handberg E; Gaxiola E; Sleight P; Conti CR; Hewkin AC; Tavazzi L;
J Am Coll Cardiol; 2006 Feb; 47(3):547-51. PubMed ID: 16458134
[TBL] [Abstract][Full Text] [Related]
8. A 26-week, prospective, open-label, uncontrolled, multicenter study to evaluate the effect of an escalating-dose regimen of trandolapril on change in blood pressure in treatment-naive and concurrently treated adult hypertensive subjects (TRAIL).
Tytus RH; Burgess ED; Assouline L; Vanjaka A
Clin Ther; 2007 Feb; 29(2):305-15. PubMed ID: 17472822
[TBL] [Abstract][Full Text] [Related]
9. The fixed combination of verapamil SR/trandolapril.
Widimský J
Expert Opin Pharmacother; 2000 Mar; 1(3):515-35. PubMed ID: 11249535
[TBL] [Abstract][Full Text] [Related]
10. Managing hypertension in diabetic patients--focus on trandolapril/verapamil combination.
Sharma SK; Ruggenenti P; Remuzzi G
Vasc Health Risk Manag; 2007; 3(4):453-65. PubMed ID: 17969376
[TBL] [Abstract][Full Text] [Related]
11. Factors influencing blood pressure response to trandolapril add-on therapy in patients taking verapamil SR (from the International Verapamil SR/Trandolapril [INVEST] Study).
Brunner M; Cooper-DeHoff RM; Gong Y; Karnes JH; Langaee TY; Pepine CJ; Johnson JA;
Am J Cardiol; 2007 Jun; 99(11):1549-54. PubMed ID: 17531579
[TBL] [Abstract][Full Text] [Related]
12. Impact of trandolapril therapy and its combination with a calcium channel blocker on plasma adiponectin levels in patients with type 2 diabetes and hypertension.
Rubio-Guerra AF; Vargas-Robles H; Vargas-Ayala G; Rodríguez-Lopez L; Castro-Serna D; Escalante-Acosta BA
Ther Adv Cardiovasc Dis; 2011 Aug; 5(4):193-7. PubMed ID: 21737486
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of hypertension in diabetics with trandolapril, an angiotensin converting enzyme inhibitor--a multicenter study].
Rosolová H; Cech F; Sefrna F
Vnitr Lek; 2002 Aug; 48(8):701-6. PubMed ID: 12425199
[TBL] [Abstract][Full Text] [Related]
14. Intervention at lower blood pressure levels to achieve target goals in type 2 diabetes: PRADID (PResión Arterial en DIabéticos tipo Dos) study.
Ruilope LM; Usan L; Segura J; Bakris GL
J Hypertens; 2004 Jan; 22(1):217-22. PubMed ID: 15106814
[TBL] [Abstract][Full Text] [Related]
15. Dual therapy in hypertensive patients with coronary artery disease: the role of calcium channel blockers and beta-blockers.
Bakris GL; Cooper-Dehoff RM; Zhou Q; Kupfer S; Champion A; Pepine CJ;
Am J Cardiovasc Drugs; 2007; 7 Suppl 1():25-9. PubMed ID: 19845074
[TBL] [Abstract][Full Text] [Related]
16. Primary prevention of renal failure in diabetic patients: the Bergamo Nephrologic Diabetes Complication Trial.
Ruggenenti P; Remuzzi G
J Hypertens Suppl; 1998 Jan; 16(1):S95-7. PubMed ID: 9534106
[TBL] [Abstract][Full Text] [Related]
17. Blood pressure and aortic elastic properties--verapamil SR/trandolapril compared to a metoprolol/hydrochlorothiazide combination therapy.
Breithaupt-Grögler K; Gerhardt G; Lehmann G; Notter T; Belz GG
Int J Clin Pharmacol Ther; 1998 Aug; 36(8):425-31. PubMed ID: 9726695
[TBL] [Abstract][Full Text] [Related]
18. [Antihypertensive treatment for patients with hypertension and diabetes type II--current clinical research].
Rajzer M; Kawecka-Jaszcz K; Wojciechowska W
Przegl Lek; 2003; 60(2):111-5. PubMed ID: 12939858
[TBL] [Abstract][Full Text] [Related]
19. Rationale and design of the International Verapamil SR/Trandolapril Study (INVEST): an Internet-based randomized trial in coronary artery disease patients with hypertension.
Pepine CJ; Handberg-Thurmond E; Marks RG; Conlon M; Cooper-DeHoff R; Volkers P; Zellig P
J Am Coll Cardiol; 1998 Nov; 32(5):1228-37. PubMed ID: 9809930
[TBL] [Abstract][Full Text] [Related]
20. [The TEAM study--a study of the effectiveness and tolerance of treatment of essential hypertension with a fixed combination of trandolapril and verapamil].
Widimský J; Dzúrik R
Vnitr Lek; 1998 Jun; 44(6):326-31. PubMed ID: 9820054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
